• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Sunday, June 7, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

AFP

US drug firms face jury over opioid addiction epidemic

Published on: June 30, 2021 12:14 PM

US pharmaceutical firms accused of stoking a two-decade epidemic of opioid addiction that has seen 500,000 die from overdoses stood trial before a jury for the first time Tuesday.

The suit launched by two counties in New York state charges the leading drugmakers and distributors with earning huge profits by pushing highly addictive prescription opioids like Oxycontin that cost local authorities billions of dollars for social services in dealing with the fallout from the epidemic. “This case is about one thing: corporate greed,” the suit says. The drug makers and distributors “put their desire for profits above the health and wellbeing” of the citizens of the counties, the suit said. On trial are firms including Actavis, Cardinal Health and Amerisource, dominant powers in the US healthcare industry. The initial complaint also included Purdue Pharma, whose involvement in the case has been paused due to bankruptcy, and Johnson & Johnson, which is no longer part of the lawsuit after announcing a settlement over the weekend, among others. Civil and criminal charges have been launched in front of judges around the country against the firms, with some of those cases resulting in negotiated settlements for heavy damages.

The case that opened in Central Islip, New York Tuesday will be the first in which the companies will be judged by a jury of citizens, who could, if convinced of their guilt, award the counties massive damages that could create a framework for similar suits and jury trials all around the country. “The evidence is going to show that the manufacturing defendants misled doctors and patients by claiming that the risk of addiction was rare,” said Jayne Conroy, who represents the Long Island county of Suffolk, one of the two counties named as plaintiffs in the suit. “The opioid epidemic didn’t happen by accident. It happened because of a calculated decision in boardrooms across the country to decide to try to make a blockbuster drug… that everyone knew was addictive, and cause death,” said Hunter Shkolnik, representing Nassau County. On the eve of the trial four major pharmacy chains including CVS and Walgreens were dropped from the list of defendants because they had reached settlements with the state, according to news reports. The trial is taking place in a university auditorium because the courtroom is not large enough to contain all of the defendants and their attorneys. It is expected to last six to eight weeks.

Filed Under: World Tagged With: Addiction, Drugs, Justice, Latest, trial, US

Submit a Comment




Primary Sidebar




Latest News

Mirra Andreeva wins French Open to claim first Grand Slam title

Antonelli pips Verstappen to Monaco pole

Iran World Cup squad heads to Mexico as US visa row erupts

Bosnia’s World Cup pursuit begins at a home-away-from home in the American Midwest

Football fans urge red card for coach who led Israeli club

Pakistan

All set for Gilgit-Baltistan Elections today

Mohsin Naqvi arrives in Tehran as Pakistan pushes for US-Iran deal

Lebanon army chief visits US-Iran mediator Pakistan

US strikes Iranian sites after Iran launches drones, in latest Gulf flare-up

72 held in AJK crackdown as government defends JAAC ban

More Posts from this Category

Business

PSX new IPOs deliver 47% average return, boosting investor confidence

Pakistan signs MoU with Saudi, local firms to develop Karachi maritime business district

Gold prices witness sharp decline

Gul Ahmed venture QGDC announces $230m investment to set up Pakistan’s largest data centre

SECP takes action against 36 government entities

More Posts from this Category

World

Trump claims Iran missile stockpile shrinking

Young ‘cockroaches’ hold first protest in New Delhi

Ukraine strikes key Russian military sites

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.